12-1840773-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_172364.5(CACNA2D4):​c.2517G>A​(p.Ala839Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.106 in 1,613,590 control chromosomes in the GnomAD database, including 10,238 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1798 hom., cov: 34)
Exomes 𝑓: 0.10 ( 8440 hom. )

Consequence

CACNA2D4
NM_172364.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: -2.06

Publications

6 publications found
Variant links:
Genes affected
CACNA2D4 (HGNC:20202): (calcium voltage-gated channel auxiliary subunit alpha2delta 4) This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
CACNA2D4 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinal cone dystrophy 4
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 12-1840773-C-T is Benign according to our data. Variant chr12-1840773-C-T is described in CliVar as Benign. Clinvar id is 100607.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-1840773-C-T is described in CliVar as Benign. Clinvar id is 100607.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-1840773-C-T is described in CliVar as Benign. Clinvar id is 100607.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-1840773-C-T is described in CliVar as Benign. Clinvar id is 100607.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-1840773-C-T is described in CliVar as Benign. Clinvar id is 100607.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-1840773-C-T is described in CliVar as Benign. Clinvar id is 100607.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-1840773-C-T is described in CliVar as Benign. Clinvar id is 100607.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.06 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.234 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA2D4NM_172364.5 linkc.2517G>A p.Ala839Ala synonymous_variant Exon 26 of 38 ENST00000382722.10 NP_758952.4 Q7Z3S7-1
CACNA2D4XM_011521041.3 linkc.2454G>A p.Ala818Ala synonymous_variant Exon 25 of 36 XP_011519343.1
CACNA2D4XM_047429897.1 linkc.2445G>A p.Ala815Ala synonymous_variant Exon 25 of 36 XP_047285853.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA2D4ENST00000382722.10 linkc.2517G>A p.Ala839Ala synonymous_variant Exon 26 of 38 1 NM_172364.5 ENSP00000372169.4 Q7Z3S7-1
CACNA2D4ENST00000586184.5 linkc.2517G>A p.Ala839Ala synonymous_variant Exon 26 of 37 5 ENSP00000465060.1 Q7Z3S7-5
CACNA2D4ENST00000587995.5 linkc.2442G>A p.Ala814Ala synonymous_variant Exon 25 of 37 5 ENSP00000465372.1 K7EJY1
CACNA2D4ENST00000585708.5 linkc.2325G>A p.Ala775Ala synonymous_variant Exon 26 of 37 5 ENSP00000467697.1 Q7Z3S7-6
CACNA2D4ENST00000588077.5 linkc.2325G>A p.Ala775Ala synonymous_variant Exon 26 of 38 5 ENSP00000468530.1 Q7Z3S7-4
CACNA2D4ENST00000444595.6 linkn.*763G>A non_coding_transcript_exon_variant Exon 26 of 37 1 ENSP00000403371.2 E7EUE0
CACNA2D4ENST00000537784.5 linkn.357G>A non_coding_transcript_exon_variant Exon 4 of 15 1 ENSP00000440231.2 X6RLU5
CACNA2D4ENST00000444595.6 linkn.*763G>A 3_prime_UTR_variant Exon 26 of 37 1 ENSP00000403371.2 E7EUE0

Frequencies

GnomAD3 genomes
AF:
0.136
AC:
20652
AN:
152100
Hom.:
1794
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.238
Gnomad AMI
AF:
0.0724
Gnomad AMR
AF:
0.0875
Gnomad ASJ
AF:
0.0942
Gnomad EAS
AF:
0.0146
Gnomad SAS
AF:
0.104
Gnomad FIN
AF:
0.105
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.105
Gnomad OTH
AF:
0.106
GnomAD2 exomes
AF:
0.104
AC:
25861
AN:
249110
AF XY:
0.102
show subpopulations
Gnomad AFR exome
AF:
0.241
Gnomad AMR exome
AF:
0.0896
Gnomad ASJ exome
AF:
0.0916
Gnomad EAS exome
AF:
0.0141
Gnomad FIN exome
AF:
0.107
Gnomad NFE exome
AF:
0.103
Gnomad OTH exome
AF:
0.101
GnomAD4 exome
AF:
0.103
AC:
149916
AN:
1461372
Hom.:
8440
Cov.:
31
AF XY:
0.102
AC XY:
74021
AN XY:
726972
show subpopulations
African (AFR)
AF:
0.235
AC:
7880
AN:
33472
American (AMR)
AF:
0.0892
AC:
3987
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0946
AC:
2470
AN:
26120
East Asian (EAS)
AF:
0.0131
AC:
519
AN:
39700
South Asian (SAS)
AF:
0.103
AC:
8914
AN:
86256
European-Finnish (FIN)
AF:
0.107
AC:
5705
AN:
53280
Middle Eastern (MID)
AF:
0.0758
AC:
437
AN:
5768
European-Non Finnish (NFE)
AF:
0.102
AC:
113692
AN:
1111688
Other (OTH)
AF:
0.105
AC:
6312
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
6657
13314
19972
26629
33286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4178
8356
12534
16712
20890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.136
AC:
20696
AN:
152218
Hom.:
1798
Cov.:
34
AF XY:
0.133
AC XY:
9889
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.238
AC:
9889
AN:
41500
American (AMR)
AF:
0.0873
AC:
1336
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0942
AC:
327
AN:
3470
East Asian (EAS)
AF:
0.0149
AC:
77
AN:
5184
South Asian (SAS)
AF:
0.104
AC:
501
AN:
4830
European-Finnish (FIN)
AF:
0.105
AC:
1109
AN:
10608
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.105
AC:
7138
AN:
68008
Other (OTH)
AF:
0.110
AC:
233
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
895
1790
2684
3579
4474
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
212
424
636
848
1060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.117
Hom.:
573
Bravo
AF:
0.137
Asia WGS
AF:
0.0920
AC:
318
AN:
3478
EpiCase
AF:
0.0955
EpiControl
AF:
0.0971

ClinVar

Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
NEI Ophthalmic Genomics Laboratory, National Institutes of Health
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal cone dystrophy 4 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
0.54
DANN
Benign
0.87
PhyloP100
-2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs33972365; hg19: chr12-1949939; COSMIC: COSV54565241; COSMIC: COSV54565241; API